PRLD icon

Prelude Therapeutics

68 hedge funds and large institutions have $235M invested in Prelude Therapeutics in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 19 closing their positions.

Holders
68
Holders Change
-7
Holders Change %
-9.33%
% of All Funds
1.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
19
Reduced
25
Closed
19
Calls
$1.52M
Puts
$20K
Net Calls
+$1.5M
Net Calls Change
+$1.47M
Name Holding Trade Value Shares
Change
Shares
Change %
SFI
76
Susquehanna Fundamental Investments
Pennsylvania
-$273K -21,900 Closed
ECM
77
ExodusPoint Capital Management
New York
-$259K -20,773 Closed
NFGH
78
Nan Fung Group Holdings
Hong Kong
-$253K -20,350 Closed
TI
79
Trexquant Investment
Connecticut
-$242K -19,458 Closed
PL
80
Parkwood LLC
Ohio
-$158K -12,667 Closed
Thrivent Financial for Lutherans
81
Thrivent Financial for Lutherans
Minnesota
-$157K -12,594 Closed
Jane Street
82
Jane Street
New York
-$128K -10,241 Closed
QT
83
Quantbot Technologies
New York
-$102K -8,200 Closed
PHK
84
Point72 Hong Kong
Hong Kong
-$48K -3,872 Closed
SOW
85
State of Wyoming
Wyoming
-$7K -544 Closed